The downregulation of miR‐34a/c, which occurs frequently in cancer, leads to an upregulation of ULBP2, thus paradoxically resulting in an increased tumor‐immune surveillance by natural killer (NK) cells (Heinemann et al., 2012). The gene discussed is ULBP2; the disease is neoplasm.